Minor Glucose Elevations Trigger Powerful Insulin-Dependent Suppression of Liver Glucose Production Read more about Minor Glucose Elevations Trigger Powerful Insulin-Dependent Suppression of Liver Glucose Production
New Diagnostic Score Enhances Detection of Arginine Vasopressin Deficiency vs. Primary Polydipsia Tags ORAL GTT Read more about New Diagnostic Score Enhances Detection of Arginine Vasopressin Deficiency vs. Primary Polydipsia
Liver Fat and Heart Risk: MASLD Scores Predict Atherosclerosis in Type 1 Diabetes Read more about Liver Fat and Heart Risk: MASLD Scores Predict Atherosclerosis in Type 1 Diabetes
Type 2 Diabetes: Why Sex Matters in Risk and Treatment Read more about Type 2 Diabetes: Why Sex Matters in Risk and Treatment
Obesity Worsens Diabetes Control: New Australian Audit Reveals Urgent Need for Weight-Focused Interventions in T2DM Management Read more about Obesity Worsens Diabetes Control: New Australian Audit Reveals Urgent Need for Weight-Focused Interventions in T2DM Management
Luseogliflozin Improves Metabolic Markers in Type 2 Diabetes, But Alcohol May Hinder Liver Fibrosis Benefits Read more about Luseogliflozin Improves Metabolic Markers in Type 2 Diabetes, But Alcohol May Hinder Liver Fibrosis Benefits
Poorly Controlled Diabetes Linked to Higher Risk of Asymptomatic Carotid Plaques in Chinese Adults Tags Coronary artery disease Coronary artery disease Read more about Poorly Controlled Diabetes Linked to Higher Risk of Asymptomatic Carotid Plaques in Chinese Adults
Hemodialysis Plus Standard Therapy Shows Biochemical and Inflammatory Benefits in Diabetic Kidney Disease: A Systematic Review Tags Diabetic Nephropathy Read more about Hemodialysis Plus Standard Therapy Shows Biochemical and Inflammatory Benefits in Diabetic Kidney Disease: A Systematic Review
Lower Estimated Glucose Disposal Rate Linked to MASLD and Dyslipidemia Risk: NHANES-Based Study Read more about Lower Estimated Glucose Disposal Rate Linked to MASLD and Dyslipidemia Risk: NHANES-Based Study
Vildagliptin Improves Glycemic Variability and Target Range in T2DM Patients on Premixed Insulin: A Controlled Study Tags Rapid acting Long acting SGLT-2 Inhibitor Read more about Vildagliptin Improves Glycemic Variability and Target Range in T2DM Patients on Premixed Insulin: A Controlled Study
